CD8+ T cells fail to limit SIV reactivation following ART withdrawal until after viral amplificationAfam A. Okoye(Oregon National Primate Research Center), Louis J. Picker(Oregon National Primate Research Center)Journal of Clinical InvestigationFebruary 25, 202110.1172/jci141677Cited by 38SaveCiteExport RISWatch citationsRelated PapersProfound early control of highly pathogenic SIV by an effector memory T-cell vaccine|Nature|2011|993Early antiretroviral therapy limits SIV reservoir establishment to delay or prevent post-treatment viral rebound|Nature Medicine|2018|128The ingenol-based protein kinase C agonist GSK445A is a potent inducer of HIV and SIV RNA transcription|PLoS Pathogens|2022|22